Order Article Reprints

Tatineni V, O’Shea PJ, Saxena S, Khosla AA, Ozair A, Kotecha RR, Jia X, Rauf Y, Murphy ES, Chao ST, et al. Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010–2019 Retrospective Cohort Study. Cancers. 2023; 15(11):3015. https://doi.org/10.3390/cancers15113015

Tatineni, Vineeth, Patrick J. O’Shea, Shreya Saxena, Atulya A. Khosla, Ahmad Ozair, Rupesh R. Kotecha, Xuefei Jia, Yasmeen Rauf, Erin S. Murphy, Samuel T. Chao, and et al. 2023. "Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010–2019 Retrospective Cohort Study" Cancers 15, no. 11: 3015. https://doi.org/10.3390/cancers15113015

Tatineni, V., O’Shea, P. J., Saxena, S., Khosla, A. A., Ozair, A., Kotecha, R. R., Jia, X., Rauf, Y., Murphy, E. S., Chao, S. T., Suh, J. H., Peereboom, D. M., & Ahluwalia, M. S. (2023). Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010–2019 Retrospective Cohort Study. Cancers, 15(11), 3015. https://doi.org/10.3390/cancers15113015